Mesothelin Redirected Autologous T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesothelin Redirected Autologous T Cells, covering 2016-03-11 to 2016-03-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma [Phase 1]